Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
4,089
JPY
|
-0.02%
|
|
+0.49%
|
+0.86%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,029,161
|
5,153,364
|
6,229,971
|
5,423,454
|
6,762,204
|
6,415,371
|
-
|
-
|
Enterprise Value (EV)
1 |
12,054,743
|
9,609,054
|
9,862,522
|
8,919,170
|
10,611,015
|
10,186,084
|
9,853,178
|
9,541,050
|
P/E ratio
|
40
x
|
118
x
|
16.6
x
|
23.8
x
|
21.3
x
|
46.4
x
|
27.6
x
|
22.5
x
|
Yield
|
3.98%
|
5.44%
|
4.52%
|
5.15%
|
4.14%
|
4.6%
|
4.64%
|
4.72%
|
Capitalization / Revenue
|
3.35
x
|
1.57
x
|
1.95
x
|
1.52
x
|
1.68
x
|
1.56
x
|
1.59
x
|
1.56
x
|
EV / Revenue
|
5.75
x
|
2.92
x
|
3.08
x
|
2.5
x
|
2.63
x
|
2.48
x
|
2.45
x
|
2.32
x
|
EV / EBITDA
|
25.3
x
|
14
x
|
9.23
x
|
8.54
x
|
9.19
x
|
9.74
x
|
8.98
x
|
8.27
x
|
EV / FCF
|
-4.81
x
|
9.99
x
|
16
x
|
8.92
x
|
28.7
x
|
29.5
x
|
14.6
x
|
14.4
x
|
FCF Yield
|
-20.8%
|
10%
|
6.26%
|
11.2%
|
3.49%
|
3.39%
|
6.86%
|
6.97%
|
Price to Book
|
1.36
x
|
1.09
x
|
1.2
x
|
0.95
x
|
1.06
x
|
1.01
x
|
1.02
x
|
1.01
x
|
Nbr of stocks (in thousands)
|
1,554,780
|
1,557,849
|
1,563,355
|
1,550,444
|
1,554,530
|
1,568,934
|
-
|
-
|
Reference price
2 |
4,521
|
3,308
|
3,985
|
3,498
|
4,350
|
4,089
|
4,089
|
4,089
|
Announcement Date
|
5/14/19
|
5/13/20
|
5/11/21
|
5/11/22
|
5/11/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,097,200
|
3,291,200
|
3,197,812
|
3,569,006
|
4,027,478
|
4,099,317
|
4,028,429
|
4,107,599
|
EBITDA
1 |
477,415
|
684,057
|
1,068,940
|
1,043,995
|
1,154,905
|
1,046,202
|
1,097,806
|
1,153,436
|
EBIT
1 |
205,000
|
100,400
|
509,269
|
460,844
|
490,505
|
267,999
|
429,150
|
489,383
|
Operating Margin
|
9.77%
|
3.05%
|
15.93%
|
12.91%
|
12.18%
|
6.54%
|
10.65%
|
11.91%
|
Earnings before Tax (EBT)
1 |
94,896
|
-60,754
|
366,235
|
302,571
|
375,090
|
132,641
|
314,185
|
387,676
|
Net income
1 |
109,100
|
44,200
|
376,005
|
230,059
|
317,017
|
134,022
|
233,930
|
291,583
|
Net margin
|
5.2%
|
1.34%
|
11.76%
|
6.45%
|
7.87%
|
3.27%
|
5.81%
|
7.1%
|
EPS
2 |
113.0
|
28.00
|
240.7
|
147.1
|
204.3
|
88.13
|
148.1
|
182.1
|
Free Cash Flow
1 |
-2,507,219
|
961,871
|
617,401
|
999,853
|
370,054
|
344,948
|
675,738
|
664,805
|
FCF margin
|
-119.55%
|
29.23%
|
19.31%
|
28.01%
|
9.19%
|
8.41%
|
16.77%
|
16.18%
|
FCF Conversion (EBITDA)
|
-
|
140.61%
|
57.76%
|
95.77%
|
32.04%
|
32.97%
|
61.55%
|
57.64%
|
FCF Conversion (Net income)
|
-
|
2,176.18%
|
164.2%
|
434.61%
|
116.73%
|
257.38%
|
288.86%
|
228%
|
Dividend per Share
2 |
180.0
|
180.0
|
180.0
|
180.0
|
180.0
|
188.0
|
189.9
|
192.9
|
Announcement Date
|
5/14/19
|
5/13/20
|
5/11/21
|
5/11/22
|
5/11/23
|
-
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2020 S2
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
2026 S1
|
---|
Net sales
1 |
1,660,200
|
1,631,000
|
1,590,785
|
844,797
|
1,794,400
|
901,294
|
873,289
|
972,465
|
1,002,340
|
1,974,800
|
1,096,551
|
956,200
|
1,058,618
|
1,043,089
|
2,101,707
|
1,111,200
|
899,902
|
1,038,000
|
1,044,000
|
2,034,000
|
1,106,000
|
959,000
|
2,060,000
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
249,972
|
340,072
|
133,355
|
-
|
291,975
|
207,900
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
50,300
|
50,100
|
215,588
|
97,448
|
346,000
|
116,484
|
-1,619
|
150,515
|
104,485
|
255,000
|
146,990
|
88,600
|
168,571
|
-49,341
|
119,230
|
104,900
|
50,750
|
94,000
|
-
|
185,500
|
-
|
-
|
210,500
|
Operating Margin
|
3.03%
|
3.07%
|
13.55%
|
11.54%
|
19.28%
|
12.92%
|
-0.19%
|
15.48%
|
10.42%
|
12.91%
|
13.4%
|
9.27%
|
15.92%
|
-4.73%
|
5.67%
|
9.44%
|
5.64%
|
9.06%
|
-
|
9.12%
|
-
|
-
|
10.22%
|
Earnings before Tax (EBT)
1 |
-27,557
|
-33,197
|
125,561
|
61,447
|
284,425
|
72,193
|
-54,047
|
155,473
|
64,549
|
220,022
|
107,153
|
47,900
|
135,033
|
-95,980
|
39,053
|
61,300
|
18,376
|
42,500
|
-
|
92,500
|
-
|
-
|
127,500
|
Net income
1 |
33,200
|
11,000
|
86,548
|
-16,778
|
183,600
|
57,769
|
-11,358
|
105,014
|
61,786
|
166,800
|
119,127
|
31,100
|
89,395
|
-48,030
|
41,365
|
105,700
|
-18,644
|
32,500
|
-
|
70,500
|
-
|
-
|
97,500
|
Net margin
|
2%
|
0.67%
|
5.44%
|
-1.99%
|
10.23%
|
6.41%
|
-1.3%
|
10.8%
|
6.16%
|
8.45%
|
10.86%
|
3.25%
|
8.44%
|
-4.6%
|
1.97%
|
9.51%
|
-2.07%
|
3.13%
|
-
|
3.47%
|
-
|
-
|
4.73%
|
EPS
2 |
21.00
|
-
|
55.45
|
-10.27
|
117.0
|
37.01
|
-6.950
|
67.94
|
40.06
|
108.0
|
76.70
|
20.03
|
57.51
|
-31.00
|
26.51
|
67.38
|
0.7722
|
20.70
|
-
|
44.90
|
-
|
-
|
62.10
|
Dividend per Share
2 |
90.00
|
-
|
90.00
|
-
|
90.00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
94.00
|
94.00
|
-
|
94.00
|
-
|
94.00
|
-
|
-
|
94.00
|
-
|
Announcement Date
|
10/31/19
|
5/13/20
|
10/29/20
|
10/28/21
|
10/28/21
|
2/3/22
|
5/11/22
|
7/28/22
|
10/27/22
|
10/27/22
|
2/2/23
|
5/11/23
|
7/27/23
|
10/26/23
|
10/26/23
|
2/1/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
5,025,582
|
4,455,690
|
3,632,551
|
3,495,716
|
3,848,811
|
3,770,713
|
3,437,808
|
3,125,679
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
10.53
x
|
6.514
x
|
3.398
x
|
3.348
x
|
3.333
x
|
3.604
x
|
3.132
x
|
2.71
x
|
Free Cash Flow
1 |
-2,507,219
|
961,871
|
617,401
|
999,853
|
370,054
|
344,948
|
675,738
|
664,805
|
ROE (net income / shareholders' equity)
|
3%
|
0.9%
|
7.6%
|
4.2%
|
5.3%
|
2.13%
|
3.88%
|
4.76%
|
ROA (Net income/ Total Assets)
|
1.06%
|
-0.46%
|
2.85%
|
2.32%
|
2.76%
|
1.03%
|
1.94%
|
2.52%
|
Assets
1 |
10,334,963
|
-9,710,018
|
13,209,937
|
9,918,859
|
11,467,260
|
12,997,037
|
12,085,642
|
11,583,413
|
Book Value Per Share
2 |
3,319
|
3,032
|
3,309
|
3,666
|
4,087
|
4,052
|
4,003
|
4,067
|
Cash Flow per Share
2 |
397.0
|
403.0
|
599.0
|
520.0
|
632.0
|
704.0
|
660.0
|
676.0
|
Capex
1 |
134,114
|
217,710
|
236,468
|
186,037
|
633,689
|
516,170
|
366,694
|
371,598
|
Capex / Sales
|
6.39%
|
6.61%
|
7.39%
|
5.21%
|
15.73%
|
12.59%
|
9.1%
|
9.05%
|
Announcement Date
|
5/14/19
|
5/13/20
|
5/11/21
|
5/11/22
|
5/11/23
|
-
|
-
|
-
|
Last Close Price
4,089
JPY Average target price
4,779
JPY Spread / Average Target +16.88% Consensus |
1st Jan change
|
Capi.
|
---|
| +0.86% | 40.76B | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|